# US 2015/0147351 A1 · Use of composition in preparing health care products or medicines for preventing and treating allergic diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147351 A1
- Document ID: US20150147351A1
- Status: Published application
- Kind: A1
- Application number: 14/403,986
- Filed: 2013-05-27
- Published: 2015-05-28
- Earliest claimed: 2012-05-29
- Assignees: Jiangzhong Pharmaceutical Co., Ltd.
- Applicants: Jiangzhong Pharmaceutical Co., Ltd.
- Inventors: Hongguang Zhong; Minzhi Yi; Jianzhong Lu
- Web page: https://patentgrep.com/patent/US20150147351A1

## CPC

- A61K 36/738: Rosa (rose)
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 36/062: Ascomycota
- A61K 36/068: Cordyceps
- A61K 36/074: Ganoderma
- A61K 36/258: Panax (ginseng)
- A61K 36/344: Codonopsis
- A61K 36/36: Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
- A61K 36/481: Astragalus (milkvetch)
- A61K 36/73: Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61P 11/06: Antiasthmatics
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 9/141: {Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers ((co) spray-dried products A61K9/16, (co) lyophilised products A61K9/19; the carrier being chemically bound to the active ingredient A61K47/50)}
- A61K 9/1605: {Excipients; Inactive ingredients}
- A61K 9/2004: {Excipients; Inactive ingredients}
- A61K 9/4841: {Filling excipients; Inactive ingredients}
- A61K 2236/39: Complex extraction schemes, e.g. fractionation or repeated extraction steps
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to use of a composition in the manufacture of health care products or medicaments for prevention and treatment of allergic diseases. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition made from water and/or alcohol extracts of the above raw materials as active components. The allergic diseases include allergic rhinitis, allergic dermatitis, urticaria, and/or allergic asthma.

## Claims

### Claim 1

A method of preventing or treating allergic diseases, comprising the step of administering to a subject in need thereof a composition made from raw materials comprising Ganoderma, Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, fermented Cordyceps sinensis powder and/or Cordyceps.

### Claim 2 (depends on 1)

The method of claim 1, characterized in that the composition further comprise one or more of Flos Rosae Rugosae, Ganoderma spore powder, Ganoderma spore oil, Radix Pseudostellariae, Folium Ginseng, Radix Codonopsis, and Radix Astragali.

### Claim 3 (depends on 1)

The method of claim 1, characterized in that the composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps.

### Claim 4 (depends on 3)

The method of claim 3, characterized in that the composition is made from the following raw materials: 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps.

### Claim 5 (depends on 3)

The method of claim 3, characterized in that there are 20 to 120 parts by weight of Ganoderma, 10 to 90 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 3 to 60 parts by weight of fermented Cordyceps sinensis powder and/or 3 to 90 parts by weight of Cordyceps.

### Claim 6 (depends on 5)

The method of claim 5, characterized in that there are 40 parts by weight of Ganoderma, 30 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 20 parts by weight of fermented Cordyceps sinensis powder and/or 6.7 parts by weight of Cordyceps.

### Claim 7 (depends on 3)

The method of claim 3, characterized in that the composition for the use may further comprise the following additional raw materials, or water and/or alcohol extracts of these additional raw materials: one or more of 5 to 90 parts by weight of Flos Rosae Rugosae, 5 to 150 parts by weight of Ganoderma spore powder, 1 to 90 parts by weight of Ganoderma spore oil, 10 to 400 parts by weight of Radix Pseudostellariae, 1 to 120 parts by weight of Folium Ginseng, 3 to 400 parts by weight of Radix Codonopsis, and 3 to 400 parts by weight of Radix Astragali, or any combination thereof.

### Claim 8 (depends on 7)

The method of claim 7, characterized in that there is one or more of 10 to 60 parts by weight of Flos Rosae Rugosae, 10 to 120 parts by weight of Ganoderma spore powder, 10 to 60 parts by weight of Ganoderma spore oil, 20 to 200 parts by weight of Radix Pseudostellariae, 20 to 90 parts by weight of Folium Ginseng, 20 to 200 parts by weight of Radix Codonopsis, and 20 to 200 parts by weight of Radix Astragali, or any combination thereof, in the composition.

### Claim 9 (depends on 8)

The method of claim 8, characterized in that there is one or more of 30 parts by weight of Flos Rosae Rugosae, 30 parts by weight of Ganoderma spore powder, 20 parts by weight of Ganoderma spore oil, 40 parts by weight of Radix Pseudostellariae, 30 parts by weight of Folium Ginseng, 40 parts by weight of Radix Codonopsis, and 40 parts by weight of Radix Astragali, or any combination thereof, in the composition.

### Claim 10 (depends on 7)

The method of claim 7, characterized in that the composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 90 parts by weight of Flos Rosae Rugosae, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps.

### Claim 11 (depends on 8)

The method of claim 8, characterized in that the composition is made from the following raw materials: 5 to 200 parts by weight of Ganoderma, 5 to 90 parts by weight of Flos Rosae Rugosae, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps.

### Claim 12 (depends on 10)

The method of claim 10, characterized in that there are 20 to 120 parts by weight of Ganoderma, 10 to 60 parts by weight of Flos Rosae Rugosae, 10 to 90 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 3 to 60 parts by weight of fermented Cordyceps sinensis powder and/or 3 to 90 parts by weight of Cordyceps.

### Claim 13 (depends on 12)

The method of claim 12, characterized in that there are 40 parts by weight of Ganoderma, 30 parts by weight of Flos Rosae Rugosae, 30 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 20 parts by weight of fermented Cordyceps sinensis powder and/or 6.7 parts by weight of Cordyceps.

### Claim 14 (depends on 1)

The method of claim 1, characterized in that the allergic diseases are allergic rhinitis, allergic dermatitis, allergic asthma, and/or urticaria.

### Claim 15 (depends on 1)

The method of claim 1, characterized in that the composition is prepared by mixing the raw materials; or by mixing the raw materials and extracting them with water and/or alcohol to obtain the composition; or by extracting one or more of the raw materials with water and/or alcohol and using the extract as the active ingredient to prepare the composition.

### Claim 16 (depends on 15)

The method of claim 15, characterized in that the composition is prepared by the following steps:
1) weighing out traditional Chinese drugs as the raw materials; and
2) extracting the raw materials under reflux with alcohol or water, so as to obtain a liquid extract as the active ingredient, and adding auxiliary agent(s) to prepare various dosage forms.

### Claim 17 (depends on 15)

The method of claim 15, characterized in that the composition is prepared by the following steps:
1) weighing out traditional Chinese drugs as the raw materials, adding methanol or ethanol thereto to carry out extraction, recovering methanol or ethanol from the extraction liquid, to obtain Extract I;
2) evaporating methanol or ethanol from the residual drugs, adding water to carry out extraction, to obtain Extract II; and
3) combining Extract I and Extract II, carrying out filtration, concentrating the filtrate to an appropriate amount, adding pharmaceutically conventional auxiliary agent(s) to prepare a desired formulation by a pharmaceutically conventional process.

### Claim 18 (depends on 15)

The method of claim 15, characterized in that the composition is prepared by the following steps:
1) raw material preparation: weighing out traditional Chinese drugs as the raw materials;
2) extraction and concentration: soaking the Chinese drug raw materials processed in step 1) in water, then decocting several times by heating, combining the liquid extracts to carry out filtration, concentrating the filtrate to an appropriate amount, cooling the concentrate and subjecting it to high-speed centrifugation to remove impurities, and reserving the product until use;
3) formulation preparation: preparing the concentrate obtained in step 2), alone or together with medicinally acceptable auxiliary agent(s), into a desired formulation by a pharmaceutically conventional process;
4) in above step 2), the soaking time is 20 to 60 min, and after soaking, decocting is carried out 1 to 3 times by heating, with each decoction lasting for 1 to 2 h and having a 6 to 13-fold amount of water added.

### Claim 19 (depends on 1)

The method of claim 1, characterized in that the compositions can be prepared into any dosage form by adding thereto auxiliary agent(s) or excipient(s) which is/are acceptable in health care products, medicaments or products.

### Claim 20 (depends on 17)

The method of claim 17, characterized in that the dosage form is any one of a tablet, an oral liquid, a granule, a capsule, an electuary, a dripping pill, a pill, powder, a lozenge, a fluid extract, an extract, an injection, and a syrup.
